SCHEMBL7708469

SCHEMBL7708469

Nc1ncc(-c2ccc(Cl)cc2)c(N2CCN(CCO)CC2)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 3/20 0.49
ROCK1 Q13464 3/20 0.49
DHFR P00374 1/20 0.45
ALDH1A1 P00352 3/20 0.42
HPGD P15428 1/20 0.42
HSD17B10 Q99714 1/20 0.42
KDM4E B2RXH2 2/20 0.42
HTT P42858 1/20 0.42
TP53 P04637 2/20 0.42
USP2 O75604 1/20 0.42
MAPT P10636 1/20 0.42
TSHR P16473 1/20 0.42
CASP1 P29466 1/20 0.42
CASP7 P55210 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
METAP1 P53582 1/20 0.41
HRH4 Q9H3N8 2/20 0.41
LMNA P02545 1/20 0.41
SRC P12931 1/20 0.41
HTR2A P28223 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7714702 0.85 HRH4 (0.58) DHFRHSD17B10HRH4KMT2A
SCHEMBL8136827 0.83 CYP1A2 (0.41) ROCK2ROCK1ALDH1A1HPGDHSD17B10
SCHEMBL7714413 0.82 ROCK2 (0.44) ROCK2ROCK1DHFRALDH1A1HPGD
SCHEMBL7712408 0.81 ROCK2 (0.43) ROCK2ROCK1DHFRALDH1A1HPGD
SCHEMBL7708442 0.81 LMNA (0.45) ROCK2ROCK1DHFRALDH1A1HPGD
SCHEMBL3250940 0.81 ROCK2 (0.43) ROCK2ROCK1DHFRALDH1A1HPGD
SCHEMBL7708451 0.81 ROCK2 (0.43) ROCK2ROCK1DHFRALDH1A1HPGD
SCHEMBL7714561 0.80 KDM4E (0.56) DHFRALDH1A1KDM4E
SCHEMBL8139191 0.78 HRH4 (0.45) ROCK2ROCK1ALDH1A1KDM4EHTT
SCHEMBL7708465 0.77 HTR7 (0.43) ROCK2ROCK1ALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP claimed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO claimed
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP disclosed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO disclosed